Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.21 - $1.24 $2,407 - $14,214
11,463 Added 3.02%
390,623 $101,000
Q4 2022

Feb 13, 2023

BUY
$0.99 - $2.91 $451 - $1,326
456 Added 0.12%
379,160 $447,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $2.27 $3,731 - $65,158
28,704 Added 8.2%
378,704 $773,000
Q2 2022

Aug 11, 2022

BUY
$1.54 - $6.48 $539,000 - $2.27 Million
350,000 New
350,000 $539,000

Others Institutions Holding PEAR

About Pear Therapeutics, Inc.


  • Ticker PEAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 138,768,992
  • Market Cap $1.39M
  • Description
  • Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...
More about PEAR
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.